\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ ruq\\ us\\ \\(films\\ \\.1\\ and\\ \\.2\\)\\ reveals\\ a\\ large\\ gallstone\\ casting\\ an\\ acoustic\\ shadow\\.\\ \\ the\\ gb\\ lumen\\ is\\ not\\ well\\-identified\\.\\ \\ there\\ is\\ an\\ area\\ of\\ increased\\ echogenicity\\ posterior\\ to\\ the\\ gallbladder\\ suspicious\\ for\\ a\\ mass\\.\\ \\ the\\ ct\\ \\(film\\ \\.3\\)\\ demonstrates\\ dilated\\ intrahepatic\\ ducts\\,\\ no\\ dilated\\ extrahepatic\\ ducts\\,\\ and\\ a\\ mass\\ partially\\ replacing\\ the\\ gb\\ lumen\\ and\\ extending\\ into\\ the\\ liver\\ posteromedially\\.\\ \\ lower\\ cuts\\ show\\ a\\ round\\ hypodensity\\ in\\ the\\ gb\\ \\(arrow\\)\\ representing\\ a\\ large\\ non\\-calcified\\ gallstone\\.\\ \\ note\\ the\\ mass\\ effect\\ against\\ the\\ contrast\\-filled\\ duodenum\\.\\ \\ a\\ ptc\\ was\\ done\\ next\\ to\\ better\\ define\\ the\\ extent\\ of\\ ductal\\ involvement\\ \\(film\\ \\.4\\)\\.\\ \\ the\\ films\\ show\\ high\\ grade\\ obstruction\\ of\\ the\\ chd\\ near\\ the\\ hilus\\ with\\ medial\\ displacement\\ of\\ the\\ duct\\ by\\ adjacent\\ tumor\\ mass\\.\\ \\ the\\ intrahepatic\\ ducts\\ are\\ markedly\\ dilated\\.\\ \\ the\\ findings\\ of\\ a\\ mass\\ partially\\ filling\\ the\\ gallbladder\\ lumen\\ and\\ extending\\ into\\ the\\ liver\\ with\\ ductal\\ obstruction\\ at\\ level\\ of\\ the\\ porta\\ hepatis\\ and\\ the\\ presence\\ of\\ a\\ gallstone\\ are\\ characteristic\\ of\\ gallbladder\\ carcinoma\\.\\ \\ this\\ diagnosis\\ was\\ surgically\\ confirmed\\.\ \(0\)\
\-\ two\\ additional\\ cases\\ of\\ gallbladder\\ carcinoma\\ demonstrating\\ characteristic\\ findings\\ on\\ imaging\\ studies\\ are\\ included\\.\\ \\ a\\ ct\\ scan\\ \\(film\\ \\.5\\)\\ from\\ a\\ patient\\ with\\ tumor\\ replacing\\ the\\ gallbladder\\ lumen\\ \\(hu\\ \\#31\\)\\ and\\ locally\\ invading\\ the\\ liver\\ is\\ shown\\.\\ \\ note\\ the\\ irregular\\ margins\\,\\ a\\ large\\ mass\\ in\\ the\\ gallbladder\\ fossa\\ and\\ the\\ presence\\ of\\ calcified\\ gallstones\\ \\(arrow\\)\\.\\ \\ us\\ \\(films\\ \\.6\\ and\\ \\.7\\)\\ and\\ ct\\ \\(film\\ \\.8\\)\\ from\\ the\\ other\\ case\\ show\\ thickening\\ of\\ the\\ gallbladder\\ wall\\ with\\ a\\ polypoid\\ intraluminal\\ mass\\.\\ \\ extension\\ into\\ the\\ adjacent\\ liver\\ and\\ multiple\\ small\\ hepatic\\ metastases\\ are\\ visible\\ on\\ the\\ ct\\.\ \(0\)\
\-\ gallbladder\\ carcinoma\\.\ \(2\)\
\-\ a\\ 69\\-year\\-old\\ woman\\ with\\ ruq\\ pain\\,\\ weight\\ loss\\ and\\ jaundice\\,\\ was\\ admitted\\ for\\ evaluation\\.\\ \\ she\\ was\\ examined\\ with\\ us\\ and\\ ct\\.\\ \\ what\\ are\\ the\\ findings\\?\\ \\ what\\ would\\ you\\ do\\ next\\?\ \(0\)\
\-\ carcinoma\\ of\\ the\\ gallbladder\\ is\\ the\\ fifth\\ most\\ common\\ cause\\ of\\ death\\ from\\ gi\\ malignancy\\.\\ \\ most\\ cases\\ occur\\ after\\ the\\ age\\ of\\ 50\\.\\ \\ gallbladder\\ carcinoma\\ is\\ three\\ times\\ more\\ frequent\\ in\\ females\\.\\ \\ there\\ is\\ a\\ high\\ association\\ \\(65\\-95\\%\\)\\ with\\ gallstones\\.\\ \\ the\\ disease\\ is\\ almost\\ always\\ advanced\\ at\\ the\\ time\\ of\\ detection\\;\\ the\\ early\\ stages\\ are\\ asymptomatic\\.\\ \\ it\\ may\\ be\\ an\\ incidental\\ finding\\ at\\ cholecystectomy\\ or\\ on\\ imaging\\ studies\\.\ \(0\)\
\-\ most\\ lesions\\ are\\ well\\-differentiated\\ adenocarcinoma\\.\\ \\ three\\ primary\\ morphologic\\ patterns\\ are\\ seen\\ \\(film\\ \\.9\\)\\:\\ \\ 1\\)\\ an\\ intraluminal\\ polypoid\\ mass\\ \\(15\\-25\\%\\)\\,\\ \\ 2\\)\\ focal\\ or\\ diffuse\\ wall\\ thickening\\ \\(20\\-30\\%\\)\\,\\ and\\ \\ 3\\)\\ a\\ fungating\\ mass\\ replacing\\ the\\ gallbladder\\ \\(40\\-65\\%\\)\\ and\\ extending\\ to\\ the\\ adjacent\\ liver\\.\\ \ \(0\)\
\-\ direct\\ spread\\ to\\ contiguous\\ structures\\ is\\ the\\ most\\ frequent\\ route\\ of\\ extension\\ and\\ involvement\\ of\\ the\\ medial\\ segment\\ of\\ the\\ left\\ lobe\\ of\\ the\\ liver\\ is\\ most\\ commonly\\ seen\\.\\ \\ biliary\\ obstruction\\ is\\ common\\.\ \(0\)\
\-\ the\\ preoperative\\ diagnosis\\ was\\ rarely\\ made\\ prior\\ to\\ ultrasound\\ and\\ ct\\;\\ ocg\\ showed\\ non\\-visualization\\.\\ \\ on\\ us\\ and\\ ct\\,\\ the\\ most\\ frequent\\ findings\\ are\\ gallstones\\ and\\ a\\ mass\\ in\\ the\\ gallbladder\\ fossa\\ extending\\ to\\ the\\ adjacent\\ liver\\.\\ \\ this\\ appearance\\ may\\ be\\ difficult\\ to\\ distinguish\\ from\\ cholecystitis\\ complicated\\ by\\ abscess\\ or\\ perforation\\.\\ \\ dilated\\ bile\\ ducts\\ from\\ tumor\\ involvement\\ and\\ obstruction\\ of\\ the\\ chd\\ may\\ also\\ be\\ seen\\.\\ \\ other\\ findings\\ seen\\ on\\ us\\ or\\ ct\\ include\\ gallbladder\\ wall\\ thickening\\,\\ an\\ intraluminal\\ polypoid\\ mass\\,\\ nodal\\ involvement\\ or\\ metastases\\.\\ \\ when\\ the\\ mass\\ is\\ confined\\ to\\ the\\ gallbladder\\,\\ the\\ sonographic\\ appearance\\ may\\ be\\ indistinguishable\\ from\\ gallstones\\ or\\ the\\ presence\\ of\\ stones\\ may\\ obscure\\ the\\ lesion\\.\ \(0\)\
\-\ when\\ biliary\\ obstruction\\ is\\ present\\,\\ direct\\ cholangiography\\ is\\ helpful\\ to\\ outline\\ the\\ exact\\ nature\\ and\\ site\\ of\\ obstruction\\.\\ \\ this\\ may\\ be\\ difficult\\ to\\ assess\\ by\\ ct\\ or\\ us\\.\\ \\ on\\ ptc\\,\\ the\\ common\\ hepatic\\ duct\\ above\\ the\\ cystic\\ in\\ the\\ area\\ of\\ the\\ porta\\ hepatis\\ is\\ most\\ frequently\\ affected\\.\\ \\ the\\ common\\ duct\\ may\\ be\\ displaced\\ medially\\ by\\ the\\ tumor\\ mass\\.\\ \\ if\\ the\\ lesion\\ extends\\ higher\\ into\\ the\\ liver\\,\\ multiple\\ sites\\ of\\ obstruction\\ can\\ be\\ present\\.\\ \\ because\\ of\\ cystic\\ duct\\ involvement\\,\\ the\\ gallbladder\\ usually\\ does\\ not\\ fill\\.\\ \\ the\\ differential\\ diagnosis\\ of\\ the\\ cholangiographic\\ appearance\\ includes\\ obstruction\\ from\\ metastatic\\ nodes\\ in\\ the\\ porta\\ hepatis\\ and\\ primary\\ cholangiocarcinoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gallbladder\\:\\ 0\\.4021576649313658\ \(0\)\
\-\ the\\:\\ 0\\.38915130932627595\ \(0\)\
\-\ obstruction\\:\\ 0\\.16813045504991225\ \(0\)\
\-\ liver\\:\\ 0\\.16558677289998883\ \(0\)\
\-\ of\\:\\ 0\\.15266437977182096\ \(0\)\
\-\ mass\\:\\ 0\\.14899089574007573\ \(0\)\
\-\ us\\:\\ 0\\.14320198196815295\ \(0\)\
\-\ and\\:\\ 0\\.13020040662822877\ \(0\)\
\-\ gallstones\\:\\ 0\\.12998394489775308\ \(0\)\
\-\ ducts\\:\\ 0\\.1237932831829878\ \(0\)\
\-\ hepatis\\:\\ 0\\.11855381000722626\ \(0\)\
\-\ porta\\:\\ 0\\.1156768394143939\ \(0\)\
\-\ is\\:\\ 0\\.11503630458615544\ \(0\)\
\-\ gb\\:\\ 0\\.11441379339725352\ \(0\)\
\-\ film\\:\\ 0\\.11210672315309092\ \(0\)\
\-\ replacing\\:\\ 0\\.1101806812292773\ \(0\)\
\-\ most\\:\\ 0\\.10930599072414618\ \(0\)\
\-\ involvement\\:\\ 0\\.1085821862476567\ \(0\)\
\-\ lumen\\:\\ 0\\.10686965310837117\ \(0\)\
\-\ polypoid\\:\\ 0\\.10611222778645935\ \(0\)\
\-\ may\\:\\ 0\\.10569373677847178\ \(0\)\
\-\ gallstone\\:\\ 0\\.10473921859740377\ \(0\)\
\-\ duct\\:\\ 0\\.10331236573080937\ \(0\)\
\-\ ct\\:\\ 0\\.10280623708355278\ \(0\)\
\-\ are\\:\\ 0\\.10246737411953438\ \(0\)\
\-\ ptc\\:\\ 0\\.09596678604894698\ \(0\)\
\-\ intraluminal\\:\\ 0\\.09194302254731114\ \(0\)\
\-\ chd\\:\\ 0\\.09170138736558278\ \(0\)\
\-\ carcinoma\\:\\ 0\\.08973605316298065\ \(0\)\
\-\ dilated\\:\\ 0\\.08595843111105635\ \(0\)\
\-\ be\\:\\ 0\\.08520078904507314\ \(0\)\
\-\ from\\:\\ 0\\.083415025934518\ \(0\)\
\-\ frequent\\:\\ 0\\.08253861180106659\ \(0\)\
\-\ extending\\:\\ 0\\.08137317569437388\ \(0\)\
\-\ adjacent\\:\\ 0\\.07779514588485972\ \(0\)\
\-\ arrow\\:\\ 0\\.07549626362482903\ \(0\)\
\-\ to\\:\\ 0\\.07501013775394004\ \(0\)\
\-\ findings\\:\\ 0\\.07404160506886832\ \(0\)\
\-\ or\\:\\ 0\\.07306570963549708\ \(0\)\
\-\ films\\:\\ 0\\.07128219930705175\ \(0\)\
\-\ common\\:\\ 0\\.06806347852706539\ \(0\)\
\-\ presence\\:\\ 0\\.06467509622234444\ \(0\)\
\-\ into\\:\\ 0\\.06379905798715271\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.06298211577060449\ \(0\)\
\-\ tumor\\:\\ 0\\.06277593979653746\ \(0\)\
\-\ thickening\\:\\ 0\\.06123723891113421\ \(0\)\
\-\ ruq\\:\\ 0\\.060912769202175525\ \(0\)\
\-\ what\\:\\ 0\\.0577002252375498\ \(0\)\
\-\ an\\:\\ 0\\.05736770052589767\ \(0\)\
\-\ show\\:\\ 0\\.05714224273487235\ \(0\)\
\-\ seen\\:\\ 0\\.05650310877583475\ \(0\)\
\-\ next\\:\\ 0\\.05603912207372909\ \(0\)\
\-\ biliary\\:\\ 0\\.05580533984071772\ \(0\)\
\-\ wall\\:\\ 0\\.05475587076508414\ \(0\)\
\-\ on\\:\\ 0\\.054370865115097214\ \(0\)\
\-\ appearance\\:\\ 0\\.05426527214204002\ \(0\)\
\-\ direct\\:\\ 0\\.052895233020806356\ \(0\)\
\-\ ductal\\:\\ 0\\.05280793154432554\ \(0\)\
\-\ was\\:\\ 0\\.05228396209054498\ \(0\)\
\-\ partially\\:\\ 0\\.05150147761343851\ \(0\)\
\-\ by\\:\\ 0\\.050966248264894404\ \(0\)\
\-\ difficult\\:\\ 0\\.04980334055781326\ \(0\)\
\-\ characteristic\\:\\ 0\\.048513592629390964\ \(0\)\
\-\ metastases\\:\\ 0\\.048513592629390964\ \(0\)\
\-\ calcified\\:\\ 0\\.04834160349811593\ \(0\)\
\-\ cholangiographic\\:\\ 0\\.04798339302447349\ \(0\)\
\-\ hepatic\\:\\ 0\\.04778780365934855\ \(0\)\
\-\ fossa\\:\\ 0\\.04710887341952867\ \(0\)\
\-\ diagnosis\\:\\ 0\\.046662035142129965\ \(0\)\
\-\ ocg\\:\\ 0\\.04585069368279139\ \(0\)\
\-\ cholangiography\\:\\ 0\\.04585069368279139\ \(0\)\
\-\ note\\:\\ 0\\.045174047916558505\ \(0\)\
\-\ large\\:\\ 0\\.04510091737523805\ \(0\)\
\-\ in\\:\\ 0\\.04478456280675989\ \(0\)\
\-\ studies\\:\\ 0\\.04401949434026303\ \(0\)\
\-\ posteromedially\\:\\ 0\\.04316381027473879\ \(0\)\
\-\ hilus\\:\\ 0\\.04316381027473879\ \(0\)\
\-\ extension\\:\\ 0\\.04247897388611442\ \(0\)\
\-\ with\\:\\ 0\\.04112650680448065\ \(0\)\
\-\ fungating\\:\\ 0\\.04069164581314674\ \(0\)\
\-\ cases\\:\\ 0\\.04036204485814193\ \(0\)\
\-\ three\\:\\ 0\\.04028244976814863\ \(0\)\
\-\ morphologic\\:\\ 0\\.03951793666907542\ \(0\)\
\-\ medial\\:\\ 0\\.039061035438404945\ \(0\)\
\-\ cuts\\:\\ 0\\.03901661620114982\ \(0\)\
\-\ obscure\\:\\ 0\\.03901661620114982\ \(0\)\
\-\ outline\\:\\ 0\\.03901661620114982\ \(0\)\
\-\ area\\:\\ 0\\.03887442712992156\ \(0\)\
\-\ indistinguishable\\:\\ 0\\.037748131812414515\ \(0\)\
\-\ route\\:\\ 0\\.03704577220748337\ \(0\)\
\-\ primary\\:\\ 0\\.036898804028606194\ \(0\)\
\-\ when\\:\\ 0\\.03624865566047829\ \(0\)\
\-\ cystic\\:\\ 0\\.03614112728773593\ \(0\)\
\-\ locally\\:\\ 0\\.03587206306341204\ \(0\)\
\-\ define\\:\\ 0\\.03491307286580126\ \(0\)\
\-\ invading\\:\\ 0\\.03491307286580126\ \(0\)\
\-\ nodal\\:\\ 0\\.03469835391934071\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.034492057526754466\ \(0\)\
\-\ high\\:\\ 0\\.03410494601367045\ \(0\)\
\-\ at\\:\\ 0\\.03399900149673512\ \(0\)\
\-\ patterns\\:\\ 0\\.033739363721729934\ \(0\)\
\-\ fill\\:\\ 0\\.03356689306482248\ \(0\)\
\-\ hu\\:\\ 0\\.033399898601819994\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.033399898601819994\ \(0\)\
\-\ examined\\:\\ 0\\.03323804325380434\ \(0\)\
\-\ exact\\:\\ 0\\.03292854906267981\ \(0\)\
\-\ hypodensity\\:\\ 0\\.03263625810445604\ \(0\)\
\-\ preoperative\\:\\ 0\\.03263625810445604\ \(0\)\
\-\ distinguish\\:\\ 0\\.03249598622443827\ \(0\)\
\-\ stages\\:\\ 0\\.03209630918553089\ \(0\)\
\-\ confined\\:\\ 0\\.03209630918553089\ \(0\)\
\-\ jaundice\\:\\ 0\\.03196955886506903\ \(0\)\
\-\ casting\\:\\ 0\\.03172486898982307\ \(0\)\
\-\ imaging\\:\\ 0\\.03153654051330956\ \(0\)\
\-\ detection\\:\\ 0\\.031267199260137886\ \(0\)\
\-\ other\\:\\ 0\\.031163419909659786\ \(0\)\
\-\ you\\:\\ 0\\.031158744206018905\ \(0\)\
\-\ contiguous\\:\\ 0\\.03094832079574695\ \(0\)\
\-\ this\\:\\ 0\\.030930044008670183\ \(0\)\
\-\ present\\:\\ 0\\.03079235229495423\ \(0\)\
\-\ shadow\\:\\ 0\\.030647674182437048\ \(0\)\
\-\ medially\\:\\ 0\\.030647674182437048\ \(0\)\
\-\ against\\:\\ 0\\.030363286882756167\ \(0\)\
\-\ females\\:\\ 0\\.03018189360492942\ \(0\)\
\-\ acoustic\\:\\ 0\\.030093490116066556\ \(0\)\
\-\ fifth\\:\\ 0\\.02983685952338692\ \(0\)\
\-\ duodenum\\:\\ 0\\.029513072161046965\ \(0\)\
\-\ death\\:\\ 0\\.02943514653176568\ \(0\)\
\-\ multiple\\:\\ 0\\.029351503338503334\ \(0\)\
\-\ echogenicity\\:\\ 0\\.029282675457016433\ \(0\)\
\-\ sites\\:\\ 0\\.029282675457016433\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.02913449991845578\ \(0\)\
\-\ bile\\:\\ 0\\.02913449991845578\ \(0\)\
\-\ cholecystitis\\:\\ 0\\.028919780971995226\ \(0\)\
\-\ lesion\\:\\ 0\\.028769448997161957\ \(0\)\
\-\ complicated\\:\\ 0\\.028450435579867518\ \(0\)\
\-\ helpful\\:\\ 0\\.028450435579867518\ \(0\)\
\-\ representing\\:\\ 0\\.028386678632325864\ \(0\)\
\-\ better\\:\\ 0\\.028323685259405654\ \(0\)\
\-\ always\\:\\ 0\\.028323685259405654\ \(0\)\
\-\ perforation\\:\\ 0\\.028323685259405654\ \(0\)\
\-\ stones\\:\\ 0\\.028323685259405654\ \(0\)\
\-\ advanced\\:\\ 0\\.028199917577963664\ \(0\)\
\-\ surgically\\:\\ 0\\.027845184279638866\ \(0\)\
\-\ assess\\:\\ 0\\.027732064139829957\ \(0\)\
\-\ extent\\:\\ 0\\.027459470306458855\ \(0\)\
\-\ higher\\:\\ 0\\.02725113084382533\ \(0\)\
\-\ times\\:\\ 0\\.027001800576773673\ \(0\)\
\-\ association\\:\\ 0\\.027001800576773673\ \(0\)\
\-\ sonographic\\:\\ 0\\.027001800576773673\ \(0\)\
\-\ almost\\:\\ 0\\.026953322042168076\ \(0\)\
\-\ spread\\:\\ 0\\.026953322042168076\ \(0\)\
\-\ suspicious\\:\\ 0\\.026810510995424384\ \(0\)\
\-\ rarely\\:\\ 0\\.02676375616516671\ \(0\)\
\-\ 31\\:\\ 0\\.0266259347318602\ \(0\)\
\-\ markedly\\:\\ 0\\.026491632531033447\ \(0\)\
\-\ nature\\:\\ 0\\.026491632531033447\ \(0\)\
\-\ visible\\:\\ 0\\.026447616510403178\ \(0\)\
\-\ included\\:\\ 0\\.025946296042477585\ \(0\)\
\-\ margins\\:\\ 0\\.025599364798147853\ \(0\)\
\-\ nodes\\:\\ 0\\.025488626312792407\ \(0\)\
\-\ gi\\:\\ 0\\.02520423901311152\ \(0\)\
\-\ displaced\\:\\ 0\\.02506761097374561\ \(0\)\
\-\ do\\:\\ 0\\.024869101235091565\ \(0\)\
\-\ segment\\:\\ 0\\.024772586898406262\ \(0\)\
\-\ demonstrating\\:\\ 0\\.024740805026662486\ \(0\)\
\-\ frequently\\:\\ 0\\.024709214038182353\ \(0\)\
\-\ extends\\:\\ 0\\.024709214038182353\ \(0\)\
\-\ affected\\:\\ 0\\.024677811653742276\ \(0\)\
\-\ round\\:\\ 0\\.024584713935410684\ \(0\)\
\-\ admitted\\:\\ 0\\.024584713935410684\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.024523551807076254\ \(0\)\
\-\ displacement\\:\\ 0\\.02446309270728173\ \(0\)\
\-\ near\\:\\ 0\\.024433121778496318\ \(0\)\
\-\ site\\:\\ 0\\.02419931067397549\ \(0\)\
\-\ there\\:\\ 0\\.02387722842465239\ \(0\)\
\-\ done\\:\\ 0\\.023866996994692156\ \(0\)\
\-\ not\\:\\ 0\\.023689960601774716\ \(0\)\
\-\ includes\\:\\ 0\\.0233316318527635\ \(0\)\
\-\ additional\\:\\ 0\\.02325941263442499\ \(0\)\
\-\ shown\\:\\ 0\\.02325941263442499\ \(0\)\
\-\ filling\\:\\ 0\\.023235558245373402\ \(0\)\
\-\ irregular\\:\\ 0\\.02316463738976101\ \(0\)\
\-\ made\\:\\ 0\\.023141208024649747\ \(0\)\
\-\ reveals\\:\\ 0\\.022823704873058015\ \(0\)\
\-\ structures\\:\\ 0\\.022545112312060175\ \(0\)\
\-\ malignancy\\:\\ 0\\.02246227778482987\ \(0\)\
\-\ incidental\\:\\ 0\\.02224098808951907\ \(0\)\
\-\ commonly\\:\\ 0\\.022201735043386326\ \(0\)\
\-\ confirmed\\:\\ 0\\.02212409697301338\ \(0\)\
\-\ occur\\:\\ 0\\.022066611332293384\ \(0\)\
\-\ above\\:\\ 0\\.02164559599324659\ \(0\)\
\-\ early\\:\\ 0\\.021628033760668474\ \(0\)\
\-\ grade\\:\\ 0\\.02157569617690181\ \(0\)\
\-\ would\\:\\ 0\\.02123948694305721\ \(0\)\
\-\ effect\\:\\ 0\\.021047615805648883\ \(0\)\
\-\ because\\:\\ 0\\.0209696901763676\ \(0\)\
\-\ weight\\:\\ 0\\.020923482993959925\ \(0\)\
\-\ does\\:\\ 0\\.020742609570232298\ \(0\)\
\-\ cause\\:\\ 0\\.020440316928503205\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.020426346445467928\ \(0\)\
\-\ showed\\:\\ 0\\.019984979224469436\ \(0\)\
\-\ finding\\:\\ 0\\.019722243136303805\ \(0\)\
\-\ differential\\:\\ 0\\.01949533441898637\ \(0\)\
\-\ abscess\\:\\ 0\\.01926660778443188\ \(0\)\
\-\ usually\\:\\ 0\\.018888812768849215\ \(0\)\
\-\ age\\:\\ 0\\.018836990834685492\ \(0\)\
\-\ diffuse\\:\\ 0\\.018816404179166493\ \(0\)\
\-\ ultrasound\\:\\ 0\\.018507203516531706\ \(0\)\
\-\ evaluation\\:\\ 0\\.01829829980976863\ \(0\)\
\-\ loss\\:\\ 0\\.01827971362869596\ \(0\)\
\-\ for\\:\\ 0\\.01818814056744435\ \(0\)\
\-\ level\\:\\ 0\\.018124327830239144\ \(0\)\
\-\ focal\\:\\ 0\\.01794721063259613\ \(0\)\
\-\ she\\:\\ 0\\.01786083950025093\ \(0\)\
\-\ include\\:\\ 0\\.017852279882787328\ \(0\)\
\-\ two\\:\\ 0\\.017818180030644414\ \(0\)\
\-\ scan\\:\\ 0\\.01780121264892917\ \(0\)\
\-\ time\\:\\ 0\\.017784299824805568\ \(0\)\
\-\ if\\:\\ 0\\.017433238604101706\ \(0\)\
\-\ lobe\\:\\ 0\\.017339309612157853\ \(0\)\
\-\ lesions\\:\\ 0\\.0172318045957495\ \(0\)\
\-\ prior\\:\\ 0\\.01678745344304625\ \(0\)\
\-\ more\\:\\ 0\\.016475564858448893\ \(0\)\
\-\ metastatic\\:\\ 0\\.016455852591390156\ \(0\)\
\-\ increased\\:\\ 0\\.01622489376380631\ \(0\)\
\-\ can\\:\\ 0\\.01574530129539261\ \(0\)\
\-\ woman\\:\\ 0\\.015626332778307828\ \(0\)\
\-\ posterior\\:\\ 0\\.015515477594660274\ \(0\)\
\-\ small\\:\\ 0\\.015477223725897778\ \(0\)\
\-\ it\\:\\ 0\\.015358777121055869\ \(0\)\
\-\ lower\\:\\ 0\\.015332225405054148\ \(0\)\
\-\ demonstrates\\:\\ 0\\.015073829454488973\ \(0\)\
\-\ case\\:\\ 0\\.015073829454488973\ \(0\)\
\-\ after\\:\\ 0\\.014555573349993483\ \(0\)\
\-\ also\\:\\ 0\\.014113158514326556\ \(0\)\
\-\ disease\\:\\ 0\\.012594735388747554\ \(0\)\
\-\ pain\\:\\ 0\\.010736639463929552\ \(0\)\
\-\ left\\:\\ 0\\.010235118003101104\ \(0\)\
\-\ patient\\:\\ 0\\.009758889564465007\ \(0\)\
\-\ no\\:\\ 0\\.009757053974228058\ \(0\)\
